Loading…

Mitochondrial Dysfunction, Oxidative Stress and Neuroinflammation in Neurodegeneration with Brain Iron Accumulation (NBIA)

The syndromes of neurodegeneration with brain iron accumulation (NBIA) encompass a group of invalidating and progressive rare diseases that share the abnormal accumulation of iron in the basal ganglia. The onset of NBIA disorders ranges from infancy to adulthood. Main clinical signs are related to e...

Full description

Saved in:
Bibliographic Details
Published in:Antioxidants 2020-10, Vol.9 (10), p.1020
Main Authors: Hinarejos, Isabel, Machuca, Candela, Sancho, Paula, Espinós, Carmen
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c458t-fbfbdebb0d7e435b516df87c58c1822397636084a3c8b992979d65f35cc3afc53
cites cdi_FETCH-LOGICAL-c458t-fbfbdebb0d7e435b516df87c58c1822397636084a3c8b992979d65f35cc3afc53
container_end_page
container_issue 10
container_start_page 1020
container_title Antioxidants
container_volume 9
creator Hinarejos, Isabel
Machuca, Candela
Sancho, Paula
Espinós, Carmen
description The syndromes of neurodegeneration with brain iron accumulation (NBIA) encompass a group of invalidating and progressive rare diseases that share the abnormal accumulation of iron in the basal ganglia. The onset of NBIA disorders ranges from infancy to adulthood. Main clinical signs are related to extrapyramidal features (dystonia, parkinsonism and choreoathetosis), and neuropsychiatric abnormalities. Ten NBIA forms are widely accepted to be caused by mutations in the genes PANK2, PLA2G6, WDR45, C19ORF12, FA2H, ATP13A2, COASY, FTL1, CP, and DCAF17. Nonetheless, many patients remain without a conclusive genetic diagnosis, which shows that there must be additional as yet undiscovered NBIA genes. In line with this, isolated cases of known monogenic disorders, and also, new genetic diseases, which present with abnormal brain iron phenotypes compatible with NBIA, have been described. Several pathways are involved in NBIA syndromes: iron and lipid metabolism, mitochondrial dynamics, and autophagy. However, many neurodegenerative conditions share features such as mitochondrial dysfunction and oxidative stress, given the bioenergetics requirements of neurons. This review aims to describe the existing link between the classical ten NBIA forms by examining their connection with mitochondrial impairment as well as oxidative stress and neuroinflammation.
doi_str_mv 10.3390/antiox9101020
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ac9fe3fff7084b0c9614b8aebba6b30b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_ac9fe3fff7084b0c9614b8aebba6b30b</doaj_id><sourcerecordid>2454152643</sourcerecordid><originalsourceid>FETCH-LOGICAL-c458t-fbfbdebb0d7e435b516df87c58c1822397636084a3c8b992979d65f35cc3afc53</originalsourceid><addsrcrecordid>eNpdks1v1DAQxSMEolXpkXskLkVqwB9xYl-QtoXCSqU9AGdr_LXrVWIXOyktf31dUiEWX8Z-7-k31miq6jVG7ygV6D2Eycc7gRFGBD2rDgnqu4YKgp__cz-ojnPeoXIEphyJl9UBpagYjB5Wv7_6KeptDCZ5GOqP99nNQRdqOK2v77yByd_a-tuUbM41BFNf2TlFH9wA4wiPudqHRTR2Y4NNi_jLT9v6LEEx16m8V1rP4zws5snV2Xr19lX1wsGQ7fFTPap-XHz6fv6lubz-vD5fXTa6ZXxqnHLKWKWQ6W1LmWK4M473mnGNOSFU9B3tEG-Baq6EIKIXpmOOMq0pOM3oUbVeuCbCTt4kP0K6lxG8_CPEtJGQJq8HK0ELZ6lzri9AhbTocKs4lO7QKYpUYX1YWDezGq3RNkwJhj3ovhP8Vm7irewZF5igAjh5AqT4c7Z5kqPP2g4DBBvnLEnLWsxI19ISffNfdBfnFMqoJGFtxzlhQpRUs6R0ijkn6_5-BiP5uCRyb0noA0dFsao</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2546882599</pqid></control><display><type>article</type><title>Mitochondrial Dysfunction, Oxidative Stress and Neuroinflammation in Neurodegeneration with Brain Iron Accumulation (NBIA)</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Hinarejos, Isabel ; Machuca, Candela ; Sancho, Paula ; Espinós, Carmen</creator><creatorcontrib>Hinarejos, Isabel ; Machuca, Candela ; Sancho, Paula ; Espinós, Carmen</creatorcontrib><description>The syndromes of neurodegeneration with brain iron accumulation (NBIA) encompass a group of invalidating and progressive rare diseases that share the abnormal accumulation of iron in the basal ganglia. The onset of NBIA disorders ranges from infancy to adulthood. Main clinical signs are related to extrapyramidal features (dystonia, parkinsonism and choreoathetosis), and neuropsychiatric abnormalities. Ten NBIA forms are widely accepted to be caused by mutations in the genes PANK2, PLA2G6, WDR45, C19ORF12, FA2H, ATP13A2, COASY, FTL1, CP, and DCAF17. Nonetheless, many patients remain without a conclusive genetic diagnosis, which shows that there must be additional as yet undiscovered NBIA genes. In line with this, isolated cases of known monogenic disorders, and also, new genetic diseases, which present with abnormal brain iron phenotypes compatible with NBIA, have been described. Several pathways are involved in NBIA syndromes: iron and lipid metabolism, mitochondrial dynamics, and autophagy. However, many neurodegenerative conditions share features such as mitochondrial dysfunction and oxidative stress, given the bioenergetics requirements of neurons. This review aims to describe the existing link between the classical ten NBIA forms by examining their connection with mitochondrial impairment as well as oxidative stress and neuroinflammation.</description><identifier>ISSN: 2076-3921</identifier><identifier>EISSN: 2076-3921</identifier><identifier>DOI: 10.3390/antiox9101020</identifier><identifier>PMID: 33092153</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Animal cognition ; Apoptosis ; Autophagy ; Basal ganglia ; Bioenergetics ; Biosynthesis ; brain iron accumulation ; Central nervous system diseases ; Choreoathetosis ; Disease ; Dystonia ; Enzymes ; Extrapyramidal system ; Genes ; Genetic screening ; Homeostasis ; Inflammation ; Iron ; Kinases ; Lipid metabolism ; Lipids ; Metabolism ; Metabolites ; Mitochondria ; mitochondrial dysfunction ; Movement disorders ; Mutation ; Neurodegeneration ; neurodegenerative disorder ; neuroinflammation ; Oxidative stress ; Phagocytosis ; Phenotypes ; Phosphorylation ; Proteins ; rare disease ; Review ; Triglycerides</subject><ispartof>Antioxidants, 2020-10, Vol.9 (10), p.1020</ispartof><rights>2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c458t-fbfbdebb0d7e435b516df87c58c1822397636084a3c8b992979d65f35cc3afc53</citedby><cites>FETCH-LOGICAL-c458t-fbfbdebb0d7e435b516df87c58c1822397636084a3c8b992979d65f35cc3afc53</cites><orcidid>0000-0003-4435-1809 ; 0000-0002-8849-0213 ; 0000-0001-9548-4359 ; 0000-0003-3439-1831</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2546882599/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2546882599?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768,75096</link.rule.ids></links><search><creatorcontrib>Hinarejos, Isabel</creatorcontrib><creatorcontrib>Machuca, Candela</creatorcontrib><creatorcontrib>Sancho, Paula</creatorcontrib><creatorcontrib>Espinós, Carmen</creatorcontrib><title>Mitochondrial Dysfunction, Oxidative Stress and Neuroinflammation in Neurodegeneration with Brain Iron Accumulation (NBIA)</title><title>Antioxidants</title><description>The syndromes of neurodegeneration with brain iron accumulation (NBIA) encompass a group of invalidating and progressive rare diseases that share the abnormal accumulation of iron in the basal ganglia. The onset of NBIA disorders ranges from infancy to adulthood. Main clinical signs are related to extrapyramidal features (dystonia, parkinsonism and choreoathetosis), and neuropsychiatric abnormalities. Ten NBIA forms are widely accepted to be caused by mutations in the genes PANK2, PLA2G6, WDR45, C19ORF12, FA2H, ATP13A2, COASY, FTL1, CP, and DCAF17. Nonetheless, many patients remain without a conclusive genetic diagnosis, which shows that there must be additional as yet undiscovered NBIA genes. In line with this, isolated cases of known monogenic disorders, and also, new genetic diseases, which present with abnormal brain iron phenotypes compatible with NBIA, have been described. Several pathways are involved in NBIA syndromes: iron and lipid metabolism, mitochondrial dynamics, and autophagy. However, many neurodegenerative conditions share features such as mitochondrial dysfunction and oxidative stress, given the bioenergetics requirements of neurons. This review aims to describe the existing link between the classical ten NBIA forms by examining their connection with mitochondrial impairment as well as oxidative stress and neuroinflammation.</description><subject>Animal cognition</subject><subject>Apoptosis</subject><subject>Autophagy</subject><subject>Basal ganglia</subject><subject>Bioenergetics</subject><subject>Biosynthesis</subject><subject>brain iron accumulation</subject><subject>Central nervous system diseases</subject><subject>Choreoathetosis</subject><subject>Disease</subject><subject>Dystonia</subject><subject>Enzymes</subject><subject>Extrapyramidal system</subject><subject>Genes</subject><subject>Genetic screening</subject><subject>Homeostasis</subject><subject>Inflammation</subject><subject>Iron</subject><subject>Kinases</subject><subject>Lipid metabolism</subject><subject>Lipids</subject><subject>Metabolism</subject><subject>Metabolites</subject><subject>Mitochondria</subject><subject>mitochondrial dysfunction</subject><subject>Movement disorders</subject><subject>Mutation</subject><subject>Neurodegeneration</subject><subject>neurodegenerative disorder</subject><subject>neuroinflammation</subject><subject>Oxidative stress</subject><subject>Phagocytosis</subject><subject>Phenotypes</subject><subject>Phosphorylation</subject><subject>Proteins</subject><subject>rare disease</subject><subject>Review</subject><subject>Triglycerides</subject><issn>2076-3921</issn><issn>2076-3921</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdks1v1DAQxSMEolXpkXskLkVqwB9xYl-QtoXCSqU9AGdr_LXrVWIXOyktf31dUiEWX8Z-7-k31miq6jVG7ygV6D2Eycc7gRFGBD2rDgnqu4YKgp__cz-ojnPeoXIEphyJl9UBpagYjB5Wv7_6KeptDCZ5GOqP99nNQRdqOK2v77yByd_a-tuUbM41BFNf2TlFH9wA4wiPudqHRTR2Y4NNi_jLT9v6LEEx16m8V1rP4zws5snV2Xr19lX1wsGQ7fFTPap-XHz6fv6lubz-vD5fXTa6ZXxqnHLKWKWQ6W1LmWK4M473mnGNOSFU9B3tEG-Baq6EIKIXpmOOMq0pOM3oUbVeuCbCTt4kP0K6lxG8_CPEtJGQJq8HK0ELZ6lzri9AhbTocKs4lO7QKYpUYX1YWDezGq3RNkwJhj3ovhP8Vm7irewZF5igAjh5AqT4c7Z5kqPP2g4DBBvnLEnLWsxI19ISffNfdBfnFMqoJGFtxzlhQpRUs6R0ijkn6_5-BiP5uCRyb0noA0dFsao</recordid><startdate>20201020</startdate><enddate>20201020</enddate><creator>Hinarejos, Isabel</creator><creator>Machuca, Candela</creator><creator>Sancho, Paula</creator><creator>Espinós, Carmen</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QR</scope><scope>7T5</scope><scope>7TO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>P64</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PKEHL</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-4435-1809</orcidid><orcidid>https://orcid.org/0000-0002-8849-0213</orcidid><orcidid>https://orcid.org/0000-0001-9548-4359</orcidid><orcidid>https://orcid.org/0000-0003-3439-1831</orcidid></search><sort><creationdate>20201020</creationdate><title>Mitochondrial Dysfunction, Oxidative Stress and Neuroinflammation in Neurodegeneration with Brain Iron Accumulation (NBIA)</title><author>Hinarejos, Isabel ; Machuca, Candela ; Sancho, Paula ; Espinós, Carmen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c458t-fbfbdebb0d7e435b516df87c58c1822397636084a3c8b992979d65f35cc3afc53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animal cognition</topic><topic>Apoptosis</topic><topic>Autophagy</topic><topic>Basal ganglia</topic><topic>Bioenergetics</topic><topic>Biosynthesis</topic><topic>brain iron accumulation</topic><topic>Central nervous system diseases</topic><topic>Choreoathetosis</topic><topic>Disease</topic><topic>Dystonia</topic><topic>Enzymes</topic><topic>Extrapyramidal system</topic><topic>Genes</topic><topic>Genetic screening</topic><topic>Homeostasis</topic><topic>Inflammation</topic><topic>Iron</topic><topic>Kinases</topic><topic>Lipid metabolism</topic><topic>Lipids</topic><topic>Metabolism</topic><topic>Metabolites</topic><topic>Mitochondria</topic><topic>mitochondrial dysfunction</topic><topic>Movement disorders</topic><topic>Mutation</topic><topic>Neurodegeneration</topic><topic>neurodegenerative disorder</topic><topic>neuroinflammation</topic><topic>Oxidative stress</topic><topic>Phagocytosis</topic><topic>Phenotypes</topic><topic>Phosphorylation</topic><topic>Proteins</topic><topic>rare disease</topic><topic>Review</topic><topic>Triglycerides</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hinarejos, Isabel</creatorcontrib><creatorcontrib>Machuca, Candela</creatorcontrib><creatorcontrib>Sancho, Paula</creatorcontrib><creatorcontrib>Espinós, Carmen</creatorcontrib><collection>CrossRef</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Biological Sciences</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied &amp; Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Antioxidants</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hinarejos, Isabel</au><au>Machuca, Candela</au><au>Sancho, Paula</au><au>Espinós, Carmen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mitochondrial Dysfunction, Oxidative Stress and Neuroinflammation in Neurodegeneration with Brain Iron Accumulation (NBIA)</atitle><jtitle>Antioxidants</jtitle><date>2020-10-20</date><risdate>2020</risdate><volume>9</volume><issue>10</issue><spage>1020</spage><pages>1020-</pages><issn>2076-3921</issn><eissn>2076-3921</eissn><abstract>The syndromes of neurodegeneration with brain iron accumulation (NBIA) encompass a group of invalidating and progressive rare diseases that share the abnormal accumulation of iron in the basal ganglia. The onset of NBIA disorders ranges from infancy to adulthood. Main clinical signs are related to extrapyramidal features (dystonia, parkinsonism and choreoathetosis), and neuropsychiatric abnormalities. Ten NBIA forms are widely accepted to be caused by mutations in the genes PANK2, PLA2G6, WDR45, C19ORF12, FA2H, ATP13A2, COASY, FTL1, CP, and DCAF17. Nonetheless, many patients remain without a conclusive genetic diagnosis, which shows that there must be additional as yet undiscovered NBIA genes. In line with this, isolated cases of known monogenic disorders, and also, new genetic diseases, which present with abnormal brain iron phenotypes compatible with NBIA, have been described. Several pathways are involved in NBIA syndromes: iron and lipid metabolism, mitochondrial dynamics, and autophagy. However, many neurodegenerative conditions share features such as mitochondrial dysfunction and oxidative stress, given the bioenergetics requirements of neurons. This review aims to describe the existing link between the classical ten NBIA forms by examining their connection with mitochondrial impairment as well as oxidative stress and neuroinflammation.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>33092153</pmid><doi>10.3390/antiox9101020</doi><orcidid>https://orcid.org/0000-0003-4435-1809</orcidid><orcidid>https://orcid.org/0000-0002-8849-0213</orcidid><orcidid>https://orcid.org/0000-0001-9548-4359</orcidid><orcidid>https://orcid.org/0000-0003-3439-1831</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2076-3921
ispartof Antioxidants, 2020-10, Vol.9 (10), p.1020
issn 2076-3921
2076-3921
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_ac9fe3fff7084b0c9614b8aebba6b30b
source Publicly Available Content Database; PubMed Central
subjects Animal cognition
Apoptosis
Autophagy
Basal ganglia
Bioenergetics
Biosynthesis
brain iron accumulation
Central nervous system diseases
Choreoathetosis
Disease
Dystonia
Enzymes
Extrapyramidal system
Genes
Genetic screening
Homeostasis
Inflammation
Iron
Kinases
Lipid metabolism
Lipids
Metabolism
Metabolites
Mitochondria
mitochondrial dysfunction
Movement disorders
Mutation
Neurodegeneration
neurodegenerative disorder
neuroinflammation
Oxidative stress
Phagocytosis
Phenotypes
Phosphorylation
Proteins
rare disease
Review
Triglycerides
title Mitochondrial Dysfunction, Oxidative Stress and Neuroinflammation in Neurodegeneration with Brain Iron Accumulation (NBIA)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-22T03%3A57%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mitochondrial%20Dysfunction,%20Oxidative%20Stress%20and%20Neuroinflammation%20in%20Neurodegeneration%20with%20Brain%20Iron%20Accumulation%20(NBIA)&rft.jtitle=Antioxidants&rft.au=Hinarejos,%20Isabel&rft.date=2020-10-20&rft.volume=9&rft.issue=10&rft.spage=1020&rft.pages=1020-&rft.issn=2076-3921&rft.eissn=2076-3921&rft_id=info:doi/10.3390/antiox9101020&rft_dat=%3Cproquest_doaj_%3E2454152643%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c458t-fbfbdebb0d7e435b516df87c58c1822397636084a3c8b992979d65f35cc3afc53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2546882599&rft_id=info:pmid/33092153&rfr_iscdi=true